RRP15 deficiency induces ribosome stress to inhibit colorectal cancer proliferation and metastasis via LZTS2-mediated β-catenin suppression.
Zhixiong DongJinhai LiWenqing DaiDongbo YuYoujuan ZhaoShuanghui LiuXuanwen LiZhengzheng ZhangRui ZhangXue LiangQingran KongShengnan JinHao JiangWei JiangChunming DingPublished in: Cell death & disease (2023)
Ribosome biogenesis (RiBi) plays a pivotal role in carcinogenesis by regulating protein translation and stress response. Here, we find that RRP15, a nucleolar protein critical for RiBi and checkpoint control, is frequently upregulated in primary CRCs and higher RRP15 expression positively correlated with TNM stage (P < 0.0001) and poor survival of CRC patients (P = 0.0011). Functionally, silencing RRP15 induces ribosome stress, cell cycle arrest, and apoptosis, resulting in suppression of cell proliferation and metastasis. Overexpression of RRP15 promotes cell proliferation and metastasis. Mechanistically, ribosome stress induced by RRP15 deficiency facilitates translation of TOP mRNA LZTS2 (Leucine zipper tumor suppressor 2), leading to the nuclear export and degradation of β-catenin to suppress Wnt/β-catenin signaling in CRC. In conclusion, ribosome stress induced by RRP15 deficiency inhibits CRC cell proliferation and metastasis via suppressing the Wnt/β-catenin pathway, suggesting a potential new target in high-RiBi CRC patients.
Keyphrases
- cell proliferation
- cell cycle arrest
- cell cycle
- end stage renal disease
- pi k akt
- ejection fraction
- chronic kidney disease
- newly diagnosed
- signaling pathway
- cell death
- stem cells
- prognostic factors
- stress induced
- peritoneal dialysis
- oxidative stress
- dna damage
- replacement therapy
- long non coding rna
- patient reported
- protein protein
- human health